HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.

AbstractBACKGROUND:
Reactive oxygen species (ROS) play a pivotal role in neointima hyperplasia after balloon injury. Molecular hydrogen has emerged as a novel antioxidant and has been proven effective in treating many diseases.
OBJECTIVES:
We aimed to determine the mechanism by which hydrogen affects neointima formation.
METHODS:
We assessed the influence of a hydrogen-rich saline solution (HRSS) by daily injection in rats. Rats were euthanized to evaluate the neointima. ROS, malondialdehyde (MDA) and superoxide dismutase (SOD) and reduced glutathione (GSH), were detected in the injured artery. Macrophage infiltration and the production of inflammatory factors (i.e., IL-6, TNF-α and NF-κB) were also observed. The in vitro effects of hydrogen on vascular smooth muscle cell (VSMC) proliferation were also measured.
RESULTS:
HRSS decreased the neointima area significantly. The neointima/media ratio was also reduced by HRSS. There was a decline in the number of PCNA-positive cells in the intima treated with HRSS. Meanwhile, HRSS ameliorated the ROS and MDA levels and increased SOD, reduced GSH levels in the injured carotid. In addition, the levels of inflammatory factors, such as IL-6, TNF-α and NF-κB p65, were attenuated by HRSS. In vitro studies also confirmed the anti-proliferative capability of the hydrogen solution and ROS generation in VSMCs induced by PDGF-BB.
CONCLUSION:
HRSS may have a protective role in the prevention of neointima hyperplasia and restenosis after angioplasty. HRSS may partially exert its role by neutralizing the local ROS and suppressing the TNF-α/NF-κB pathway.
AuthorsZhe-xue Qin, Pan Yu, De-hui Qian, Ming-bao Song, Hu Tan, Yang Yu, Wei Li, Hang Wang, Jie Liu, Qiang Wang, Xue-jun Sun, Hong Jiang, Jin-kun Zhu, Wei Lu, Lan Huang
JournalAtherosclerosis (Atherosclerosis) Vol. 220 Issue 2 Pg. 343-50 (Feb 2012) ISSN: 1879-1484 [Electronic] Ireland
PMID22153150 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Antioxidants
  • Inflammation Mediators
  • Interleukin-6
  • NF-kappa B
  • Proto-Oncogene Proteins c-sis
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Becaplermin
  • Sodium Chloride
  • Malondialdehyde
  • Hydrogen
  • Superoxide Dismutase
  • Glutathione
Topics
  • Angioplasty, Balloon
  • Animals
  • Antioxidants (administration & dosage, pharmacology)
  • Becaplermin
  • Carotid Arteries (drug effects, immunology, metabolism, pathology)
  • Carotid Artery Injuries (drug therapy, etiology, immunology, metabolism, pathology)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Disease Models, Animal
  • Glutathione (metabolism)
  • Hydrogen (administration & dosage, blood, pharmacology)
  • Inflammation Mediators (metabolism)
  • Injections, Intraperitoneal
  • Interleukin-6 (metabolism)
  • Malondialdehyde (metabolism)
  • Muscle, Smooth, Vascular (drug effects, immunology, injuries, metabolism)
  • Myocytes, Smooth Muscle (drug effects, immunology, metabolism)
  • NF-kappa B (metabolism)
  • Proto-Oncogene Proteins c-sis (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction (drug effects)
  • Sodium Chloride (administration & dosage, blood, pharmacology)
  • Superoxide Dismutase (metabolism)
  • Time Factors
  • Tumor Necrosis Factor-alpha (metabolism)
  • Tunica Intima (drug effects, immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: